3-Bromo-6-methylimidazo[1,2-a]pyridine(CAS: 866135-71-9)

3-Bromo-6-methylimidazo[1,2-a]pyridine (CAS: 866135-71-9) falls under the GHS classification for carcinogenicity. It is subject to REACH regulations in the European Union, requiring registration, evaluation, authorization, and restriction. In the United States, it falls under similar EPA regulations including reporting and toxicity control under the Toxic Substances Control Act (TSCA).

Alternatives to 3-Bromo-6-methylimidazo[1,2-a]pyridine include other brominated or methylated imidazo[1,2-a]pyridines, such as 3-methylimidazo[1,2-a]pyridine or 6-bromomethylimidazo[1,2-a]pyridine, which can serve as useful intermediates in similar reactions.

Research trends for 3-Bromo-6-methylimidazo[1,2-a]pyridine (CAS: 866135-71-9) indicate increasing interest in its use as a precursor for drug development and material science applications. Market trends show a growing demand in pharmaceuticals and specialty chemicals, driven by its unique chemical properties.

Waste containing 3-Bromo-6-methylimidazo[1,2-a]pyridine (CAS: 866135-71-9) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration may be necessary, following local environmental protection guidelines, to ensure complete destruction and minimize environmental impact.